Feline idiopathic cystitis (FIC) is a condition commonly seen in small animal practice, and is the subject of this week's Evidence Based Update (EBU). In the USA alone it is estimated that, annually, between 250,000 to 500,000 cats experience a bout of lower urinary tract disease.
The clinical course of FIC is variable ranging from acute and self-limiting, to chronic or recurrent episodes that result in urethral obstruction. Previous studies have reported that over 50% of cats that develop urethral obstruction may experience a repeat obstruction in the future.
The etiology is believed to be multifactorial, and stress appears to play a significant role in the pathogenesis of this condition. These were introductory remarks by Dr. Dennis Chew, in his presentation on the management of FIC.
Recent veterinary literature includes articles on various aspects of managing feline idiopathic cystitis patients. One recent report in JAVMA, reported on the long-term management of acute nonobstructive idiopathic cystitis in cats through manipulation of the diet.
In this week's Evidence Based Update (available for viewing On Demand), we discuss another recent article that reported on the efficacy of glycosaminoglycan (GAG) infusion into the urinary bladder (intravesicle administration of a commercially available product) in preventing the short-term recurrence of obstruction in affected cats.
View this Evidence Based Update (running time 11 mins; Approved for CE credit in New York and by the NJVMA, pending approval for CE credit by AAVSB RACE).
